AllSides Balanced Search reveals information and ideas from all sides of the political spectrum so you can get the full picture.
Nov 29 2020
News
UK secures 2 million more doses of Moderna's COVID-19 vaccine
Britain has secured two million doses of Moderna Inc’s COVID-19 vaccine candidate, to be available in Europe as early as the spring, the government said on Sunday, in addition to the 5 million doses it secured from the U.S. company two weeks ago.
The new deal came a day after Prime Minister Boris Johnson named Nadhim Zahawi, a junior business minister, to be minister responsible for the
ReutersDec 20 2021
News
Moderna says its booster significantly raises the level of antibodies to thwart Omicron.
A booster shot of the Moderna coronavirus vaccine significantly raises the level of antibodies that can thwart the Omicron variant, the company announced on Monday.
The news arrives as Omicron rapidly advances across the world, and most coronavirus vaccines seem unable to stave off infection from the highly contagious variant.
Moderna’s results show that the currently authorized
New York Times (News)Dec 16 2021
News
CDC vaccine advisers vote to recommend Pfizer, Moderna vaccines over J&J's
Vaccine advisers to the US Centers for Disease Control and Prevention voted 15-0 Thursday to change recommendations for Covid-19 vaccines to make clear that shots made by Moderna and Pfizer/BioNTech are preferred over Johnson & Johnson's vaccine.
The new recommendation: "mRNA vaccines are preferred over the Janssen Covid-19 vaccine for the prevention of Covid-19 for those 18 years
CNN (Online News)Nov 19 2021
News
FDA authorizes Pfizer-BioNTech and Moderna COVID-19 boosters for all adults
The Food and Drug Administration on Friday approved COVID-19 booster shots from Pfizer-BioNTech and Moderna for all adults, opening a new chapter in the vaccine rollout and allowing the Biden administration to catch up to states that advised residents to seek an extra dose regardless of eligibility.
Senior regulators said they want to act quickly to backfill waning immunity and
Washington TimesAug 07 2020
Fact Check
Does Anthony Fauci Own ‘Half the Patent’ for Moderna’s COVID Vaccine?
In a recent debate with Alan Dershowitz, Robert Kennedy Jr. claimed that Dr. Anthony Fauci holds a patent for one of the drugs in vaccine trials for coronavirus. “The problem is Anthony Fauci put $500 million of our dollars into that vaccine [being produced by Moderna]. He owns half the patent,” said Kennedy. “He and these five guys who are working for him were entitled to collect royalties
The DispatchMar 23 2024
News
The Boston area built a ton of lab space. Now many of those buildings are opening empty.
Around this time three years ago, while most of us navigated pandemic life, real estate developers across Greater Boston looked to life-science laboratories, and saw dollar signs. The white-collar office workers who’d long filled downtown towers were largely staying home (unless they worked in commercial real estate). The future of cities had rarely been murkier. But many biotech companies,
Boston.comJun 14 2022
News
FDA committee recommends Moderna two-dose Covid vaccine for kids ages 6 to 17
Moderna’s two-dose Covid-19 vaccine for kids ages 6 through 17 received the endorsement from the Food and Drug Administration’s committee of independent immunization experts on Tuesday, a key step on the path to distributing it to kids.
The committee unanimously voted to recommend the shots for use in kindergarteners through high schoolers after an all-day public meeting that weighed
CNBCOct 21 2021
News
CDC advisers set to vote on Moderna, J&J boosters, mixing and matching doses
An independent Centers for Disease Control and Prevention advisory committee on Thursday is set to discuss and vote on booster shots for the Moderna and Johnson & Johnson COVID-19 vaccines, along with the potential for people to mix and match their booster doses.
On Wednesday, the FDA authorized Moderna and J&J boosters for some, and allowed for mix and matching booster doses
ABC News (Online)Oct 14 2021
News
FDA vaccine advisers are meeting to consider Moderna Covid-19 vaccine boosters
Vaccine advisers to the US Food and Drug Administration are meeting Thursday to discuss whether to authorize boosters of Moderna's coronavirus vaccine for some adults.
It's the first portion of a two-day Vaccines and Related Biological Products Advisory Committee meeting that will also include a vote on boosters for the Johnson & Johnson vaccine and a presentation on mix-and-match
CNN (Online News)Oct 14 2021
News
FDA Panel Unanimously Recommends Authorization of Moderna COVID-19 Vaccine Booster
A Food and Drug Administration (FDA) advisory panel voted unanimously on Thursday to recommend the agency let millions of Americans get a booster of Moderna’s COVID-19 vaccine.
The 19–0 vote came after hours of discussions and presentations in an all-virtual meeting.
Moderna officials presented data from clinical trials, including a small trial that studied the safety and
The Epoch Times